Your browser doesn't support javascript.
loading
Bariatric Surgery in Kidney Transplant Candidates and Recipients: Experience at an Asian Center.
Tan, Sarah Ying Tse; Lee, Phong Ching; Ganguly, Sonali; Kek, Peng Chin; Kee, Terence; Ho, Quan Yao; Thangaraju, Sobhana.
Afiliación
  • Tan SYT; Department of Endocrinology, Singapore General Hospital, Singapore.
  • Lee PC; Department of Endocrinology, Singapore General Hospital, Singapore.
  • Ganguly S; Department of Endocrinology, Singapore General Hospital, Singapore.
  • Kek PC; Department of Endocrinology, Singapore General Hospital, Singapore.
  • Kee T; Department of Renal Medicine, Singapore General Hospital, Singapore.
  • Ho QY; SingHealth Duke-National University of Singapore Transplant Centre, Singapore.
  • Thangaraju S; Department of Renal Medicine, Singapore General Hospital, Singapore.
J Obes Metab Syndr ; 31(4): 325-333, 2022 Dec 30.
Article en En | MEDLINE | ID: mdl-36416037
ABSTRACT

Background:

Kidney transplant (KT) candidates and recipients with obesity experience more frequent complications such as infection, poorer allograft outcomes, diabetes, and mortality, limiting their eligibility for transplantation. Bariatric surgery (BS) is not commonly performed among KT patients given concerns about immunosuppression absorption, wound healing, infections, and graft outcomes. Its role has not been described before in an Asian KT patient setting.

Methods:

A retrospective review of patients who underwent BS at the largest KT center in Singapore from 2008 to 2020 was conducted. Metabolic outcomes, immunosuppression doses, graft outcomes, and mortality were studied.

Results:

Seven patients underwent BS and KT (4 underwent BS before KT, 3 underwent BS after KT; 4 underwent sleeve gastrectomy, 3 underwent gastric bypass). Mean total weight losses of 23.8% at 1 year and 18.6% at 5 years post-BS were achieved. Among the five patients with diabetes, glycemic control improved after BS. There were no deaths in the first 90 days or graft loss in the first year after KT and BS. Patients who underwent BS after KT had no significant changes in immunosuppression dose.

Conclusion:

BS can be safely performed in KT recipients and candidates and results in sustainable weight losses and improvements in metabolic comorbidities. Although no major complications were observed in our study, close monitoring of this complex group of patients is imperative.
Palabras clave

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Obes Metab Syndr Año: 2022 Tipo del documento: Article País de afiliación: Singapur

Texto completo: 1 Colección: 01-internacional Idioma: En Revista: J Obes Metab Syndr Año: 2022 Tipo del documento: Article País de afiliación: Singapur